Uncomplicated Urinary Tract Infection
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Tianjin GreenPine PharmaChina - Tianjin
1 program1
Pivmecillinam hydrochloride tabletsPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Tianjin GreenPine PharmaPivmecillinam hydrochloride tablets
Paratek PharmaceuticalsOmadacycline tablets
Clinical Trials (2)
Total enrollment: 524 patients across 2 trials
Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection
Start: Sep 2022Est. completion: Feb 2024299 patients
Phase 3Completed
Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis
Start: Jan 2018Est. completion: Jun 2019225 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.